BenzingaOctober 19, 2026 at 5:11 AM NY8 Days Ago
Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $65
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $55 to $65.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
